Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome. the study from Jiangsu,China of 5 years follow-up

Diabetes Research and Clinical Practice

Volumn 81, Issue 1, 2008, Pages 117-123

  Liu, Shi Jun ^a   Guo, Zhi Rong ^a   Hu, Xiao Shu ^b   Wu, Ming ^c   Chen, Feng Mei ^a   Kang, Guo Dong ^a   Zhou, Hui ^a   Guo, Lu ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Health Bureau of JiangSu Province   (China)

^c Center for Disease Control and Prevention of JiangSu Province   (China)

Author keywords

Cohort study; Interaction analysis; Metabolic syndrome; Type 2 diabetes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHINA; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALIDITY; RISK FACTOR; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CHINA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK; RISK ASSESSMENT; SOCIETIES, MEDICAL; UNITED STATES;

EID: 44649163182     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.03.008     Document Type: Article

References (27)

1. Reaven G.M. Banting lecture, Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Lorenzo C., Okoloise M., Williams K., Stern M.P., and Haffner S.M. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26 (2003) 3153-3159
3. Hanley A.J., Karter A.J., Williams K., Festa A., D'Agostino Jr. R.B., Wagenknecht L.E., et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 24 (2005) 3713-3721
4. Laaksonen D.E., Lakka H.M., Niskanen L.K., Kaplan G.A., Salonen J.T., and Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156 (2002) 1070-1077
5. Kahn R., Buse J., Frerrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement for the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
6. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus, Diabetes Care 26 (2003) 3160-3167.
7. Novoa F.J., Boronat M., Saavedra P., Diaz-Cremades J.M., Varillas V.F., La Roche F., et al. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde study. Diabetes Care 28 (2005) 2388-2393
8. Ilanne-Parikka P., Eriksson J.G., Lindstrom J., Hamalainen H., Keinanen-Kiukaanniemi S., Laakso M., et al. Finnish Diabetes Prevention Study Group Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 27 (2004) 2135-2140
9. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
10. Noale M., Maggi S., Marzari C., Limongi F., Gallina P., Bianchi D., et al., ILSA Working Group. Components of the metabolic syndrome and incidence of diabetes in elderly Italians: the Italian Longitudinal Study on Aging. Atherosclerosis 187 (2006) 385-392
11. Nakanishi N., Takatorige T., Fukuda H., Shirai K., LI W., Okamoto M., et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diab. Res. Clin. Pract. 64 (2004) 59-70
12. Klein B.E., Klein R., and Lee K.E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care 25 (2002) 1790-1794
13. Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA 285 (2001) 2486-2497.
14. Tan C.-E., Ma S., Wai D., Chew S.-K., and Tai E.-S. Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians. Diabetes Care 27 (2004) 1182-1186
15. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus, The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 (2003) 3160-3167
16. Breslow N.E., and Day N.E. Statistical Methods in Cancer Research, Vol I. The Analysis of Case-Control Studies (1980), IARC, Lyon (France)
17. Hallqvist J., Ahlbom A., Diderichsen F., and Reuterwall C. How to evaluate interaction between causes: a review of practices in cardiovascular epidemiology. J. Intern. Med. 239 (1996) 377-382
18. Hosmer D.W., and Lemeshow S. Confidence interval estimation of interaction. Epidemiology 3 (1992) 452-456
19. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
20. Hanson R.L., Imperatore G., Bennett P.H., and Knowler W.C. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51 (2002) 3120-3127
21. Reaven G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu. Rev. Med. 44 (1993) 121-131
22. Alberti K.G.G., Zimmet P.Z., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
23. Despres J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
24. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 Diabetes Mellitus. Circulation 112 (2005) 3066-3072
25. Grundy S.M. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J. Am. Coll. Cardiol. 47 (2006) 1093-1100
26. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
27. The Diabetes Prevention Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N. Engl. J. Med. 346 (2002) 393-403.